معرفی
Arisbel B Gondin is a Research Fellow at the Drug Discovery Biology department within the Monash Institute of Pharmaceutical Sciences at Monash University in Melbourne, Victoria. They specialize in GPCR structural biology and pharmacology, with a focus on using sdAbs and nanobodies for their research.
Dr. Gondin's research interests span multiple areas of molecular pharmacology and receptor biology:
- GPCR structural biology and pharmacology
- Opioid receptor signaling and drug development
- Nanobody-based therapeutic approaches
- Gastrointestinal motility disorders
- Pain relief mechanisms and opioid pharmacology
Analysis of Dr. Gondin's recent publications reveals a strong focus on G protein-coupled receptors (GPCRs), particularly opioid receptors. Their work spans structural biology, pharmacology, and translational research with implications for pain management and gastrointestinal disorders. A notable trend is the investigation of allosteric modulation of opioid receptors, which could lead to analgesics with fewer side effects.
Dr. Gondin has received no publicly listed scientific awards mentioned in the available information.
As a postdoctoral researcher, Dr. Gondin is likely involved in mentoring junior researchers and collaborating on grant-funded projects, though specific details about students and grants are not available in the provided information.
Dr. Gondin is part of the Drug Discovery Biology team at Monash Institute of Pharmaceutical Sciences, which focuses on understanding disease mechanisms at the molecular level to develop new therapeutic approaches.
